Table 6. Kaplan–Meier Survival Analysis Stratified by Sarcopenia Status.
| Cohort | Median Follow-up (days) | IQR (days) |
| Median follow-up was shorter in sarcopenic patients compared to non-sarcopenic patients. A log-rank test demonstrated a statistically significant difference in survival distributions between the two groups (χ2 = 6.13, P = 0.0133), indicating worse long-term survival among sarcopenic patients. IQR: interquartile ranges. This table summarizes the median follow-up times and interquartile ranges (IQR) for sarcopenic and non-sarcopenic patients, as well as for the overall cohort. | ||
| Sarcopenic | 809.0 | 350.0–1403.0 |
| Non-Sarcopenic | 1244.0 | 518.5–1993.5 |
| Overall Cohort | 984.5 | 442.8–1845.5 |
| Log-rank test | χ² = 6.13 | P = 0.0133 |